List View Detail View 1-25 of 66 items Sort by: Best Match Name Clone Applications Regulatory Status 1 2 3 Next Product Clone Appl. Reg Cat# Size Price Quantity FITC anti-human CD103 Ber-ACT8 FC ASR 984806 500 µL 249 CHF APC anti-human CD103 Ber-ACT8 FC ASR 984808 500 µL 370 CHF PE anti-human CD103 Ber-ACT8 FC ASR 984804 500 µL 322 CHF Purified anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC, WB, IP, IHC-F RUO 350202 100 µg 126 CHF Biotin anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350220 100 µg 211 CHF PE anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350205 25 tests 117 CHF 350206 100 tests 252 CHF APC anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350215 25 tests 125 CHF 350216 100 tests 291 CHF FITC anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350203 25 tests 107 CHF 350204 100 tests 221 CHF GMP FITC anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC GMP-RUO 260328 100 tests 235 CHF GMP APC anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC GMP-RUO 260458 100 tests 347 CHF PerCP/Cyanine5.5 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350225 25 tests 136 CHF 350226 100 tests 293 CHF APC/Cyanine7 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350227 25 tests 147 CHF 350228 100 tests 311 CHF PE/Cyanine7 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350211 25 tests 171 CHF 350212 100 tests 335 CHF GMP PE anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC GMP-RUO 260330 100 tests 305 CHF TotalSeq™-A0145 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 PG RUO 350231 10 µg 369 CHF TotalSeq™-C0145 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 PG RUO 350233 10 µg 369 CHF TotalSeq™-B0145 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 PG RUO 350235 10 µg 369 CHF TotalSeq™-D0145 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 PG RUO 350241 10 µg 369 CHF Alexa Fluor® 647 anti-human CD103 (Integrin αE) Antibody Ber-ACT8 FC RUO 350209 25 tests 171 CHF See more size options for this product on the next page. Results Per Page: 25 50 100 200 1 2 3 Next
Follow Us